Mercury Laboratories Ltd

NSE: MERCURYLAB · BSE: 538964 · Pharmaceuticals & Biotechnology · 27 announcements

Share price: ₹765.00
Market cap: ₹91.80 Cr
Revenue (annual): ₹75.94 Cr
Net profit (annual): ₹4.83 Cr
P/E (TTM): 28.7×Sector 43.8×
Promoter holding: 73.66%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

5 Nov 2026 11:21 IST BSE

Financial Results

Mercury Laboratories Q2 FY27 Results: Net Profit ₹0.7 Cr, Down 56.2% YoY

Mercury Laboratories Ltd reported unaudited financial results for the quarter ended September 30, 2026. The company recorded a net profit of ₹0.67 Crore.

Key figure: Net profit ₹0.7 Cr · -56.2% YoY

Open full results → Read the filing ↗